Search results
Some hawking stem cells say they can treat almost anything. They can't – KION546
KION 46 Salinas· 2 hours agoThe mailings promised “Life Without Pain!” via stem cell injections or IVs administered in a...
Advances in medulloblastoma treatment for children
Medical Xpress· 19 hours agoMedulloblastomas are embryonal tumors that grow from embryonal cells left over from fetal development. About 500 children in the U.S. are diagnosed with medulloblastoma each year. Medulloblastomas ...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 3 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread ...
City of Hope Receives Grants For Stem Cell Lab
Los Angeles Business Journal· 5 days agoDuarte-based City of Hope has been awarded more than $11 million in grants from California’s stem cell institute in recent weeks.
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 2 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 2 days agoThe patient developed severe gastrointestinal symptoms four months after receiving CAR T-cell...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 3 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
New Scientist· 2 days agoA CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for...
New findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
Medical Xpress· 4 days agoCurrently, the CD55 protein is difficult to target because of its protective role in the immune...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 17 hours agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...